title: The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.
abstract: The global incidence of metabolic syndrome (MetS) is dramatically increasing. Considerable interest has been devoted to the relationship between MetS and prostate cancer (PCa) risk. However, few studies have examined the association between MetS and PCa progression. This retrospective study consisted of 1016 patients with PCa who received radical prostatectomy. The association between MetS and pathological features was evaluated using logistic regression analysis. Compared with patients without MetS, those with MetS indicated an increased risk of prostatectomy Gleason score (GS) ≥8 (odds ratio [OR] =1.670, 95% confidence interval (CI) 1.096-2.545, P= 0.017), and a 1.5-fold increased risk of pT3-4 disease (OR = 1.583, 95% CI 1.106-2.266, P= 0.012). The presence of MetS was an independent predictor of lymph node involvement (OR = 1.751, 95% CI 1.038-2.955, P= 0.036). Furthermore, as the number of MetS components accumulated, the risk of a GS ≥ 8 increased. The present study indicates a significant association between MetS and advanced PCa. The results need to be evaluated in large-scale prospective cohorts.
authors: Gui-Ming
authors: GM
authors: Zhang
authors: Yao
authors: Y
authors: Zhu
authors: Da-Hai
authors: DH
authors: Dong
authors: Cheng-Tao
authors: CT
authors: Han
authors: Cheng-Yuan
authors: CY
authors: Gu
authors: Wei-Jie
authors: WJ
authors: Gu
authors: Xiao-Jian
authors: XJ
authors: Qin
authors: Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
authors: Li-Jiang
authors: LJ
authors: Sun
authors: Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
authors: Ding-Wei
authors: DW
authors: Ye
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000368:Aged; D002681:China; D015897:Comorbidity; D006801:Humans; D015994:Incidence; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D008875:Middle Aged; D060787:Neoplasm Grading; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D012189:Retrospective Studies
references: Cancer Causes Control. 2013 Jan;24(1):107-16
references: 23149498
references: BJU Int. 2012 Feb;109(4):515-9
references: 21812901
references: Asian Pac J Cancer Prev. 2012;13(10):4999-5002
references: 23244098
references: BJU Int. 2005 Apr;95(6):751-6
references: 15794776
references: Asian J Androl. 2013 Nov;15(6):747-52
references: 24036920
references: Eur Urol. 2015 Jan;67(1):64-70
references: 24568896
references: Asian Pac J Cancer Prev. 2014;15(9):4029-32
references: 24935591
references: Korean J Urol. 2012 Sep;53(9):593-7
references: 23060995
references: Asian J Androl. 2014 Nov-Dec;16(6):878-83
references: 25038177
references: Clin Gastroenterol Hepatol. 2013 Aug;11(8):934-43
references: 23466711
references: Prostate. 2011 Oct 1;71(14):1492-8
references: 21360562
references: Epidemiol Rev. 2001;23(1):3-13
references: 11588851
references: BJU Int. 2014 May;113(5b):E75-81
references: 24274674
references: J Nutr Health Aging. 2014 Jan;18(1):22-5
references: 24402384
references: Nat Rev Endocrinol. 2014 Aug;10(8):455-65
references: 24935119
references: J Diabetes. 2010 Sep;2(3):180-93
references: 20923483
references: BMC Public Health. 2011;11:35
references: 21226967
references: World J Gastroenterol. 2014 May 14;20(18):5177-90
references: 24833848
references: Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557-63
references: 9264267
references: Ann Epidemiol. 2001 Nov;11(8):534-42
references: 11709272
references: Metab Syndr Relat Disord. 2009 Aug;7(4):279-88
references: 19284314
references: Digestion. 2012;86(4):294-301
references: 23095334
references: Am J Epidemiol. 2006 Oct 15;164(8):769-74
references: 16952929
references: Pharmacol Rev. 2004 Dec;56(4):549-80
references: 15602010
references: BJU Int. 2013 Jun;111(7):1031-6
references: 22883053
references: BJU Int. 2014 Jun;113(6):986-92
references: 24053309
references: Asian Pac J Cancer Prev. 2014;15(4):1879-83
references: 24641424
references: Menopause. 2013 Dec;20(12):1301-9
references: 23571527
references: Blood Press. 2004;13(1):47-55
references: 15083641
references: Eur J Cancer. 2005 Dec;41(18):2887-95
references: 16243513
references: Circulation. 2004 Sep 7;110(10):1245-50
references: 15326067
references: Cancer Causes Control. 1999 Aug;10(4):245-51
references: 10482482
references: Urol Oncol. 2013 Oct;31(7):1054-9
references: 23020926
references: Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707
references: 23549401
references: Urol Int. 2011;87(3):270-5
references: 21876327
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Br J Cancer. 2013 Jan 15;108(1):222-8
references: 23169288
references: Diabetes Res Clin Pract. 2005 Mar;67(3):251-7
references: 15713358
references: Urology. 2009 Jul;74(1):185-90
references: 19428088
references: Growth Horm IGF Res. 2004 Aug;14(4):261-9
references: 15231294